1. Home
  2. VSTM vs NTRB Comparison

VSTM vs NTRB Comparison

Compare VSTM & NTRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Verastem Inc.

VSTM

Verastem Inc.

HOLD

Current Price

$7.79

Market Cap

723.8M

Sector

Health Care

ML Signal

HOLD

Logo Nutriband Inc.

NTRB

Nutriband Inc.

N/A

Current Price

$4.56

Market Cap

71.7M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
VSTM
NTRB
Founded
2010
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Industrial Specialties
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
723.8M
71.7M
IPO Year
2012
N/A

Fundamental Metrics

Financial Performance
Metric
VSTM
NTRB
Price
$7.79
$4.56
Analyst Decision
Strong Buy
Buy
Analyst Count
9
1
Target Price
$13.38
$13.00
AVG Volume (30 Days)
2.1M
23.5K
Earning Date
11-04-2025
12-11-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$13,379,000.00
$2,278,321.00
Revenue This Year
$183.10
$30.17
Revenue Next Year
$271.39
$3,394.36
P/E Ratio
N/A
N/A
Revenue Growth
33.79
12.69
52 Week Low
$3.46
$3.72
52 Week High
$11.25
$11.78

Technical Indicators

Market Signals
Indicator
VSTM
NTRB
Relative Strength Index (RSI) 33.40 37.70
Support Level $9.13 $4.35
Resistance Level $9.91 $4.77
Average True Range (ATR) 0.62 0.42
MACD -0.32 0.03
Stochastic Oscillator 6.43 19.04

Price Performance

Historical Comparison
VSTM
NTRB

About VSTM Verastem Inc.

Verastem Inc is late-stage development biopharmaceutical company, committed to advancing new medicines for patients battling cancer. Its pipeline is focused on novel anticancer agents that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, particularly RAF/MEK inhibition and FAK inhibition.

About NTRB Nutriband Inc.

Nutriband Inc is engaged in the development of a portfolio of transdermal pharmaceutical products. AVERSA technology is the company's product that incorporates aversive agents to prevent the Abuse, Diversion, Misuse, and Accidental exposure of drugs with abuse potential specifically Opioids. The majority of the revenue is generated from the sale of goods that include consumer transdermal and coated products.

Share on Social Networks: